Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Capital Employed (2016 - 2025)

Creative Medical Technology Holdings has reported Return on Capital Employed over the past 15 years, most recently at 93.84% for Q4 2025.

  • Quarterly Return on Capital Employed fell 480.0% to 93.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 93.84% through Dec 2025, down 480.0% year-over-year, with the annual reading at 88.33% for FY2025, 1966.0% down from the prior year.
  • Return on Capital Employed was 93.84% for Q4 2025 at Creative Medical Technology Holdings, up from 97.83% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 214.89% in Q2 2021 and troughed at 97.83% in Q3 2025.
  • The 5-year median for Return on Capital Employed is 59.62% (2022), against an average of 36.66%.
  • Year-over-year, Return on Capital Employed skyrocketed 18737bps in 2021 and then crashed -24732bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 50.83% in 2021, then dropped by -15bps to 58.52% in 2022, then increased by 15bps to 49.99% in 2023, then crashed by -78bps to 89.04% in 2024, then fell by -5bps to 93.84% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Return on Capital Employed are 93.84% (Q4 2025), 97.83% (Q3 2025), and 79.47% (Q2 2025).